HIV surveillance, 1 January to 31 March 2014.

National Notifiable Diseases Surveillance System, 1 January to 31 March 2017.

A summary of diseases currently being reported by each jurisdiction is provided in Table 1. There were 67,031 notifications to the National Notifiable Diseases Surveillance System (NNDSS) between 1 January to 31 March 2016 (Table 2). The notification rate of diseases per 100,000 population for each state or territory is presented in Table 3. Table 1: Reporting of notifiable diseases by jurisdic...

Two years of Truvada for pre-exposure prophylaxis utilization in the US

INTRODUCTION Truvada® (TVD) was approved in July 2012 by the US FDA for pre-exposure prophylaxis (PrEP) in combination with safer sex practices to reduce the risk of sexually acquired HIV-1 in high-risk adults. This study explores the characteristics of US PrEP users and their prescribers over the past two years. MATERIALS AND METHODS A previously described algorithm was used to identify TVD ...

National Notifiable Diseases Surveillance System, 1 January to 31 March 2015.

Invasive pneumococcal disease surveillance Australia, 1 January to 31 March 2014.

Invasive pneumococcal disease (IPD) is caused by the bacterium Streptococcus pneumoniae and results in illnesses such as pneumonia, bacteraemia and meningitis. There are currently more than 90 serotypes recognised worldwide, approximately half of which are found in Australia where IPD has been a nationally notifiable disease since 2001. The Communicable Diseases Network Australia established th...

Genetic Testing for Predisposition to Inherited Hypertrophic Cardiomyopathy

Professional Institutional Original Effective Date: March 26, 2012 Original Effective Date: March 26, 2012 Revision Date(s): April 8, 2013; December 31, 2013; March 31, 2015; January 1, 2016; February 17, 2016; January 1, 2017; April 12, 2017; January 1, 2018 Revision Date(s): April 8, 2013; December 31, 2013; March 31, 2015; January 1, 2016; February 17, 2016; January 1, 2017; April 12, 2017; ...